GGrantIndex
Sort

11,323 grants matching glioblastoma

Targeting AVIL in Glioblastoma

$489,873
Hui Li · University Of Virginia · R01 · FY2020 · CA

Development of Clinical Strategies to Prevent GBM Recurrences After Radiotherapy

$489,573
John Martin Brown · Stanford University · R01 · FY2011 · CA

Salicylic acid-based small-molecule Stat3 inhibitors for anticancer therapy

$489,360
James K Turkson · University Of Hawaii At Manoa · R01 · FY2012 · CA

Novel DGKalpha inhibitors and immunotherapy for GBM and melanoma brain metastasis

$489,274
Benjamin W. Purow · University Of Virginia · R01 · FY2018 · CA

Deciphering the phosphorylation pattern of RNA polymerase II for eukaryotic transcription

$489,218
Yan Jessie Zhang · University Of Texas At Austin · R35 · FY2023 · GM

Imaging Brain Metabolism Using MRS of Hyperpolarized 13C-Pyruvate

$489,075
Daniel M Spielman · Stanford University · R01 · FY2016 · EB

Development of Parametric Response Mapping Software for Clinical Cancer Response Assessment

$489,069
Lauren Keith · Imbio, Llc · R44 · FY2018 · CA

The Role of Collagen and its Signaling Mechanisms in Glioma Progression and Invasion.

$489,027
Pedro R Lowenstein · University Of Michigan At Ann Arbor · R01 · FY2024 · NS

Targeted Delivery of Brain Penetrating DNA Nanoparticles to Brain Tumors

$488,981
Justin S. Hanes · Johns Hopkins University · R01 · FY2019 · CA

Allergic Condition Susceptibility Polymorphisms and Glioma Risk

$488,884
Judith Schwartzbaum · Ohio State University · R01 · FY2012 · CA

Influence of Anti-Angiogenic Therapy on Drug Delivery to Brain Tumors

$488,787
William F Elmquist · University Of Minnesota · R01 · FY2014 · NS

Mechanisms of Chemo/Radioresistance in Human Gliomas

$488,678
John J Laterra · Hugo W. Moser Res Inst Kennedy Krieger · R01 · FY2007 · NS

Mechanisms of Chemo/Radioresistance in Human Gliomas

$488,618
John J Laterra · Hugo W. Moser Res Inst Kennedy Krieger · R01 · FY2006 · NS

Development of Clinical Strategies to Prevent GBM Recurrences After Radiotherapy

$488,241
John Martin Brown · Stanford University · R01 · FY2012 · CA

Sialylation in the Maintenance and Metabolic Plasticity of Neural Stem Cell-Like Brain Tumor Cells

$488,076
Anita Borton Hjelmeland · University Of Alabama At Birmingham · R01 · FY2025 · NS

Understanding EGF receptor activation by growth factors and oncogenic mutations

$487,870
Mark A. Lemmon · Yale University · R01 · FY2024 · CA

Assaying GBM growth and therapy response in single cells and tumorspheres (PQ17)

$487,338
Keith L Ligon · Dana-Farber Cancer Inst · R01 · FY2014 · CA

IDO1 and Immunotolerance in Glioblastoma

$487,318
Derek Alan Wainwright · Loyola University Chicago · R01 · FY2024 · NS

Interstitial Fluid Flow Regulates Glioma Cell Invasion

$486,846
Jennifer M Munson · Virginia Polytechnic Inst And St Univ · R37 · FY2022 · CA

MR Metabolic Imaging of Response to Targeted Therapies in GBM

$486,781
Sabrina Miriam Ronen · University Of California, San Francisco · R01 · FY2015 · CA

Systemic Delivery of Targeted Bi-Compartmental Nanoparticles for Glioblastoma Therapeutics

$486,665
Joerg Lahann · University Of Michigan At Ann Arbor · R01 · FY2022 · NS

Targeting AVIL in Glioblastoma

$486,645
Hui Li · University Of Virginia · R01 · FY2022 · CA

Targeting AVIL in Glioblastoma

$486,645
Hui Li · University Of Virginia · R01 · FY2023 · CA

Validation of Therapeutic Target Genes in Human Liver Cancer

$486,618
Snorri Thorgeirsson · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA

RNA-binding Factors Controlling Neurogenesis and Neurodegeneration

$486,357
Myriam Gorospe · National Institute On Aging · ZIA · FY2016 · AG